Sort
48,018 grants matching “immunotherapy”
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA
$476,399Hsian-Rong Tseng · University Of California Los Angeles · P01 · FY2015 · CA
Developmental Funds
$476,285Steven K. Libutti · Rbhs -Cancer Institute Of New Jersey · P30 · FY2021 · CA
Developmental Funds
$476,270Steven K. Libutti · Rbhs -Cancer Institute Of New Jersey · P30 · FY2020 · CA
Cytokines driving T cell dysregulation in lacrimal gland autoimmunity
$476,248Scott Matthew Lieberman · University Of Iowa · R01 · FY2021 · EY
Clinical Core
$476,136Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · CA
Iron oxide nanotheranostics for breast cancer
$476,097Miqin Zhang · University Of Washington · R01 · FY2021 · EB
Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication
$476,070Dimitra Peppa · University Of Oxford · R01 · FY2020 · AI
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
$476,037Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Virus-Like Particle Based Antigen Display as Multi-component Anticancer Vaccines
$476,018Xuefei Huang · Michigan State University · R01 · FY2012 · CA
Enhancing HSPC CAR-mediated immunity in vivo
$475,999Scott G Kitchen · University Of California Los Angeles · U19 · FY2022 · AI
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
$475,986Darell D Bigner · Duke University · P01 · FY2019 · CA
Project-002
$475,984Margaret M Madeleine · Fred Hutchinson Cancer Center · U54 · FY2023 · CA
IN VIVO TREATMENT OF EAE WITH ANTI I-A ANTIBODIES
$475,945Stanford University · R01 · FY2000 · NS
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
$475,922Jessie Villanueva · Wistar Institute · R01 · FY2023 · CA
Gonorrhea and HIV prevention with intravaginal ring drug delivery
$475,901Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R33 · FY2021 · AI
Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy
$475,893George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA
Clinical production of viral vectors for cancer gene therapy
$475,840Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Autophagy proteins in the immune response to Mycobacterium tuberculosis infection
$475,781Christina Leigh Stallings · Washington University · R01 · FY2019 · AI
Analysis of galectin-8 and its ligands in melanoma progression
$475,743Charles J Dimitroff · Florida International University · R01 · FY2024 · CA
Biodegradable Polymer Nanodiscs as Novel Lipoprotein-Mimicking Nanocarriers for Anticancer Drug Delivery with High Stability and Long Circulation Time
$475,726Hongjun Liang · Texas Tech University Health Science Center · · FY2022 · MPS
Duke-UNC Chapel Hill Immunotherapy Training Grant
$475,705Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · T32 · FY2019 · CA
Project 1: Delta immune Ecology of NSCLC
$475,697Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2024 · CA
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
$475,682Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
$475,682Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Development of new treatments for rare CNS tumors
$475,654Marta Penas-Prado · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA